Blood Cancer Journal is an open access, peer‑reviewed medical journal dedicated to hematologic cancers and related disorders. It publishes original research, reviews, clinical trials, genomic studies, and guidelines in blood cancer care. The journal has a strong reputation with a high impact factor and ranks among the top publications in hematology and oncology. It aims to connect laboratory discoveries with clinical practice, helping improve patient care. Known for its rapid review process, it provides timely decisions for authors and ensures research reaches the medical community quickly. It continues to be a trusted source for both scientists and clinicians.